4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-n-methylpyridine-2-carboxamide,
BAY 73-4506,
BAY-73-4506,
BAY73-4506,
regorafenib,
Stivarga,
Regorafenib,
755037-03-7,
BAY 73-4506,
Stivarga,
Regorafenibum,
4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide,
Regorafenib (BAY 73-4506),
BAY73-4506,
UNII-24T2A1DOYB,
BAY-73-4506,
4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,
24T2A1DOYB,
CHEMBL1946170,
CHEBI:68647,
Stivarga (TN),
BAY73-4506 hydrochloride,
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,
Regorafenib [USAN:INN],
Fluoro-Sorafenib,
4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl}amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide,
Regorafenib (USAN/INN),
RegorafenibBAY73-4506,
BAY-734506 monohydrate,
MLS006010303,
C21H15ClF4N4O3,
SCHEMBL432230,
Regorafenib,BAY 73-4506,
GTPL5891,
QCR-85,
BAY73-4506(Regorafenib)/,
Regorafenib(BAY 73-4506),
DTXSID60226441,
EX-A058,
Regorafenib - BAY 73-4506,
SYN1169,
FNHKPVJBJVTLMP-UHFFFAOYSA-N,
BCPP000352,
HMS3654K16,
Regorafenib, 755037-03-7,
AOB87754,
BCP02105,
KS-00000Q4Q,
ZINC6745272,
ABP000611,
BDBM50363397,
MFCD16038047,
s1178,
AKOS015951107,
ACN-036634,
AM81251,
BAY 734506,
BCP9000384,
CS-0170,
DB08896,
RL04875,
SB16819,
NCGC00263138-01,
NCGC00263138-13,
4CA-1083,
AC-25075,
AJ-56815,
AK106990,
AS-16304,
CJ-13100,
HY-10331,
SC-28977,
SMR004701370,
AB0008044,
AB1008457,
AX8232295,
FT-0674338,
R0142,
ST24023156,
SW218097-2,
cas:835621-07-3;Regorafenib hydrochloride,
Regorafenib (BAY73-4506 Fluoro-Sorafenib),
A25020,
D10138,
S-7780,
AB01565826_02,
SR-01000941571,
SR-01000941571-1,
BRD-K16730910-001-02-4,
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-,
2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-,
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide,
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carbox,
4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide,
835621-08-4,
Regorafenib;1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea,
Regorafenib hydrate,
anhydrous regorafenib,
Regorafenib [INN],
DAST,
regorafenib monohydrate,
D09GDD,
cc-195,
Regorafenib(BAY73-4506),
Regorafenib, 98% - 10MG 10mg,
AN-1324,
CS-T-41574,
CID11167602,
CID 11167602,
A8236,
A10250,
C559147,
4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-n-methylpyridine-2-carboxamide,
4-(4-(2-(4-Chloro-3-(trifluoromethyl)phenylamino)-2-oxoethyl)-3-fluorophenoxy)-N-methylpicolinamide,